Axonova is a cutting-edge laboratory catering to the biotech and medical sectors. Established in 2016, the company offers a wide range of services and solutions across various industries, including biotechnology, health care, and pharmaceuticals. Axonova operates through two distinct business models, leveraging its advanced technologies and skilled professionals to provide an extensive portfolio of bio-analysis and research services. Additionally, the company has a significant focus on innovation, actively developing its own pipeline of pharmaceutical drug candidates with a particular emphasis on researching new molecules for neurodegenerative disorders, inspired by the local biodiversity. These assets are then licensed-out for further development. Currently, there is no available information regarding the company's headquarter location, last investment, or the investors involved in the latest funding round.
There is no investment information
No recent news or press coverage available for Axonova.